Pfizer
Developer of prescription medicines and vaccines across oncology, internal medicine, immunology and infectious disease.
$27.95
After-hours close−0.01 (−0.04%)
At close$27.96(−0.21%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $0.79 | — | — |
| Aug 2026 | $0.68 | $0.77 | +12.9% |
| May 2026 | $0.72 | $0.75 | +3.9% |
| Feb 2026 | $0.57 | $0.66 | +16.4% |
| Nov 2025 | $0.63 | $0.87 | +37.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Jan 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Jan 2023 | |||
| Nov 2022 | |||
| Jul 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Jan 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Jan 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| May 2018 | |||
| Jan 2018 | |||
| Oct 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Jan 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Oct 2015 | |||
| Jul 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | $0.79 | — | — | $15.93B | — | — |
| Aug 4, 2026 | $0.68 | $0.77 | +12.9% | $14.40B | $15.03B | +4.4% |
| May 5, 2026 | $0.72 | $0.75 | +3.9% | $13.84B | $14.45B | +4.4% |
| Feb 3, 2026 | $0.57 | $0.66 | +16.4% | $16.85B | $17.56B | +4.2% |
| Nov 4, 2025 | $0.63 | $0.87 | +37.4% | $16.50B | $16.65B | +0.9% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 5, 2025 | ||||||
| Apr 29, 2025 | ||||||
| Feb 4, 2025 | ||||||
| Oct 29, 2024 | ||||||
| Jul 30, 2024 | ||||||
| May 1, 2024 | ||||||
| Jan 30, 2024 | ||||||
| Oct 31, 2023 | ||||||
| Aug 1, 2023 | ||||||
| May 2, 2023 | ||||||
| Jan 31, 2023 | ||||||
| Nov 1, 2022 | ||||||
| Jul 28, 2022 | ||||||
| May 3, 2022 | ||||||
| Feb 8, 2022 | ||||||
| Nov 2, 2021 | ||||||
| Jul 28, 2021 | ||||||
| May 4, 2021 | ||||||
| Feb 2, 2021 | ||||||
| Oct 27, 2020 | ||||||
| Jul 28, 2020 | ||||||
| Apr 28, 2020 | ||||||
| Jan 28, 2020 | ||||||
| Oct 29, 2019 | ||||||
| Jul 29, 2019 | ||||||
| Apr 30, 2019 | ||||||
| Jan 29, 2019 | ||||||
| Oct 30, 2018 | ||||||
| Jul 31, 2018 | ||||||
| May 1, 2018 | ||||||
| Jan 30, 2018 | ||||||
| Oct 31, 2017 | ||||||
| Aug 1, 2017 | ||||||
| May 2, 2017 | ||||||
| Jan 31, 2017 | ||||||
| Nov 1, 2016 | ||||||
| Aug 2, 2016 | ||||||
| May 3, 2016 | ||||||
| Feb 2, 2016 | ||||||
| Oct 27, 2015 | ||||||
| Jul 28, 2015 | ||||||